CCL19 and adrenal cortex carcinoma: We could confirm this expression pattern by investigating CCR7 expression in publicly available RNA sequencing datasets from TCGA [34] and GTEx [35], where ACC again had lower expression of CCR7, as well as its ligands CCL19 and CCL21 compared to normal adrenal glands (Figure 3B).